Company news

OpSens Inc news in 2023

OpSens Inc's news releases, calls and decks from 2023, newest first.

View company

Haemonetics completes acquisition of OpSens

December 12, 2023

OpSens receives final order for arrangement with haemonetics

December 8, 2023

OpSens' shareholders approve arrangement with haemonetics

December 1, 2023

OpSens obtains regulatory clearance of arrangement in the united states and Canada; regulatory approvals condition satisfied

November 28, 2023

OpSens announces fourth quarter and fiscal year 2023 Financial results

November 22, 2023

Independent proxy advisory firm ISS recommends shareholders vote "for" OpSens Inc. plan of arrangement with haemonetics corporation

November 13, 2023

OpSens receives interim order and files management information circular in connection with special meeting of shareholders

November 2, 2023

OpSens announces the positive clinical results from the SAFE-TAVI study with SavvyWire in europe

October 23, 2023

OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in San Francisco October 23 - 26, 2023

October 17, 2023

OpSens signs definitive agreement for its acquisition by haemonetics

October 10, 2023

OpSens announces a third consecutive quarter of record revenues for third quarter fiscal 2023

July 13, 2023

OpSens to host third quarter fiscal year 2023 financial results conference call on Thursday July 13, 2023

July 6, 2023

OpSens announces inclusion of SavvyWire(tm) in complete TAVR study

May 10, 2023

OpSens Announces Participation in the 2023 Bloom Burton & Co. Healthcare Investor Conference

April 20, 2023

OpSens announces record revenue for second quarter fiscal 2023

April 13, 2023

OpSens announces completion of enrollment in SAFE-TAVI study with SavvyWire® in Europe

April 11, 2023

OpSens to host second quarter fiscal year 2023 financial results conference call on Thursday April 13, 2023

April 6, 2023

OpSens announces 1,000th SavvyWire procedure

April 5, 2023

OpSens appoints John Hannigan as Chief Financial Officer

March 27, 2023

OpSens awarded interventional specialty diagnostics agreement with Premier for SavvyWire(tm)

March 14, 2023

OpSens announces SavvyWire(tm) used during two live cases at CRT conference

February 28, 2023

OpSens Reports Annual General and Special Shareholders Meeting Voting Results

January 25, 2023

OpSens to participate in the lytham partners investor select conference

January 25, 2023

OpSens announces record first quarter fiscal 2023 Financial results

January 12, 2023

OpSens to host first quarter fiscal year 2023 financial results conference call on Thursday January 12, 2023

January 5, 2023

Decks in 2023